Researchers also found that a single dose of the vaccine was 76 percent effective at preventing COVID-19
WHO Team Probing COVID-19 Origins Visits Wuhan Research Center
WHO team has visited hospitals, research institutes, and a traditional wet market linked to many of the first cases
Can Blood Thinners Keep Certain COVID-19 Patients Out of the ICU?
One of many troubling complications of infection with the SARS-CoV-2 coronavirus is its ability to trigger the formation of multiple blood clots, said Francis S. Collins, M.D., Ph.D.
It raises the question of whether and when more aggressive blood-thinning treatments might improve outcomes for people hospitalized for COVID-19, continued Dr. Collins’s blog published on February 2, 2021.
The answer to this question is desperately needed to help guide clinical practice.
A Triumph for Injectable PrEP
A presentation on the HPTN 084 study delivered on January 27, 2021, confirmed the results announced when the trial was stopped early in November 2020 but added new details.
This presentation focused on women randomly allocated to receive injectable PrEP (every eight weeks) or oral PrEP (every day).
The study used a 'double-dummy' design, meaning that half the participants got active injectable cabotegravir and inactive placebo pills; the other half got inactive placebo injections and active tenofovir/emtricitabine pills.
>60 Percent Receiving COVID-19 Vaccine in U.S. Are Non-Hispanic Whites
Of those having received their first dose by Jan. 14, 2021, 63.0 percent were women, 55.0 percent were aged 50 years and older
Psychological Distress High Among Students During COVID-19
10.5 percent of students self-reported psychological distress; increased odds seem for those in high school, those who exercise less
Lack of Staff, PPE Hinder Nursing Homes’ Fight Against COVID-19
Although worker turnover in the nursing home industry has always been high, the pandemic has worsened the problem
Moderna Wants to Increase Number of Doses in COVID-19 Vaccine Vials
However, there are potential downsides to putting more vaccine in each vial
Mother’s HPV Status Impacts Oral HPV Persistence for Offspring
The results of a new study focused on 0ral Human Papillomavirus (HPV) infections in children during the first six years of life indicate that HPV infection can be acquired non-sexually and is already common at an early age.
This longitudinal study found children acquire their first oral HPV infection at an early age.
The US Centers for Disease Control and Prevention (CDC) published an Early Release, Volume 27, Number 3, March 2021, based on an extensive study in Finland.
Protein-based COVID-19 Vaccine Candidate Switches Adjuvant Partner
Clover Biopharmaceuticals and Dynavax Technologies Corporation announced their plan to initiate a global Phase 2/3 efficacy trial with the S-Trimer COVID-19 vaccine candidate adjuvanted, with CpG 1018 plus alum in the first half of 2021.
In a press release on February 1, 2021, the companies stated an interim analysis for vaccine efficacy may become available in the middle of 2021.
Clover stated it expects to produce hundreds of millions of vaccine doses in 2021 and up to 1 billion vaccine doses in peak annual production as required by global demand.